Cabotegravir for preventing HIV-1 in adults and young people (TA1106)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 5 November 2025
HIV testing: increasing uptake among people who may have undiagnosed HIV (NG60)Product type:GuidanceProgramme:NICE guidelineLast updated: 26 September 2025Published: 1 December 2016
Cabotegravir with rilpivirine for treating HIV-1 (TA757)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 5 January 2022